Objective: Good test-retest reliability of high frequency (Ն8 kHz) pure-tone audiometry (HFPTA) is essential to detect significant changes in hearing threshold caused by ototoxicity. While the test-retest reliability of HFPTA in adults has been extensively studied, such investigations in children are scant. This study aimed to evaluate the test-retest reliability of the HFPTA in normal-hearing children with particular reference to the criteria for ototoxicity.
INTRODUCTION
Although assessing hearing acuity in the frequency range from 0.25 to 8 kHz has become routine clinical practice, evaluating hearing sensitivity beyond 8 kHz has received relatively little attention. Based on data from normal-hearing adults using a release-from-masking technique, Fausti et al. (1982) provided evidence that responses to auditory stimulation in the range from 8 to 14 kHz are the result of genuine high-frequency perception rather than the perception of some lower frequency distortions. The literature revealed that children and young healthy adults with a negative otologic history can perceive pure tones up to 20 kHz (Beiter & Talley 1976; Fausti et al. 1981 Fausti et al. , 1990 Frank 1990; Buren et al. 1992) .
High-frequency (Ն8 kHz) pure-tone audiometry (HFPTA) has been successfully applied to adults for the purpose of identifying significant threshold shifts caused by ototoxicity (Fausti et al. 1994 (Fausti et al. , 1999 . For ototoxic insults resulting from anticancer chemotherapy, significant hearing threshold shifts occur at the highest measurable frequencies and then spread to lower frequencies with further drug exposure (Fausti et al. 1992 (Fausti et al. , 1993 . Thus, HFPTA holds promise as a useful tool to detect hearing damage at the earliest possible time. The early detection of hearing damage not only warns clinicians to the status of the auditory insult but also provides an opportunity for them to balance the therapeutic effects of anticancer drugs with the risks of permanent hearing loss.
In serial testing to monitor hearing in patients undergoing anticancer chemotherapy, it is essential to use hearing tests that have high test-retest reliability. To achieve the goal of detecting ototoxicity, it is important to have the intrasubject threshold variability across test-retest conditions smaller than a genuine threshold shift caused by ototoxic effects (Frank 2001) . Frank (2001) and Schmuziger et al. (2004) , in their test-retest reliability studies on normal-hearing adults, showed that thresholds varied by up to 10 dB in at least 94% of all measurements from 8 to 16 kHz. When the changes in hearing thresholds were checked against the American Speech-Language Hearing Association (ASHA) (1994) criteria for cochleotoxicity, the false-positive rates were Ͻ3% of all ears tested. Frank (2001) and Schmuziger et al. (2004) , therefore, recommended HFPTA to be used for monitoring hearing in patients receiving potentially ototoxic drugs. Although extensive investigations of the test-retest reliability of HFPTA in adults are prevalent, similar studies in children are lacking.
Only a few articles have described the test-retest reliability of HFPTA in children (Margolis et al. 1993; Hunter et al. 1996; Reuter et al. 1998) . For instance, Margolis et al. (1993) studied the effects of otitis media on extended high-frequency hearing in children with a small scale study on the test-retest reliability. Reuter et al. (1998) focused only on HFPTA test-retest reliability in preschool children. These pediatric HFPTA studies noted two significant findings. First, test-retest differences were greatest between 16 and 20 kHz. This is thought to be due to the shorter wavelengths of higher frequency stimuli being more likely to create variations in stimuli intensity at the ear drum with changes in headphone placement. Second, testretest differences at these extended-high frequencies were slightly greater than those in the conventional frequency range (Margolis et al. 1993; Hunter et al. 1996) . Mixed findings were reported on whether test-retest differences show systematic variance with frequency (Margolis et al. 1993; Hunter et al. 1996; Reuter et al. 1998 ).
Although the above three studies provided useful information about the variability of HFPTA thresholds in children, they did not report test-retest reliability as a function of frequency and age, and the sample sizes were small. In particular, Hunter et al. (1996) who had the highest number of participants measured test-retest reliability of HFPTA thresholds in a control group of 21 children. Pure-tone thresholds were measured under one of two conditions: (1) with removal and replacement of the earphones between tests (N ϭ 14); and (2) without removal and replacement of the headphones (N ϭ 7). When the headphones were not removed between tests, the test-retest correlation coefficient was 0.98 for all frequencies between 9 and 20 kHz combined. In this condition, mean absolute (always positive) test-retest differences were between 0.5 and 4 dB across all frequencies with no systematic variance with frequency. With removal and replacement of the headphones, the correlation coefficient was 0.96. However, the mean absolute test-retest threshold differences ranged from 4 to 8 dB and increased as a function of frequency. Overall, the authors found that test-retest threshold differences were greater for children than for young adults as reported by other researchers using the same method and instrumentation (Fausti et al. 1990 ). As expected, Hunter et al. (1996) reported the largest test-retest differences in pure-tone thresholds at 16 to 20 kHz in children when the earphones were removed and replaced. They concluded that test-retest variability was mostly low and acceptable for clinical use (e.g., Յ5 dB) for frequencies Ͻ16 kHz. However, they provided no further justifications on the clinical applications of HFPTA in relation to the ASHA (1994) criteria for cochleotoxicity.
According to ASHA (1994) , ototoxicity is assumed to have occurred in patients receiving ototoxic drugs if a deterioration in pure-tone threshold Ն20 dB at any one test frequency, or a deterioration Ն10 dB at any two adjacent test frequencies, is noted when compared to previous (baseline) test results. While these ASHA criteria were suggested for pure-tone audiometry in the conventional frequency range (0.25-8 kHz), their applicability to the extended high-frequency range (9 -16 kHz) is yet to be confirmed in children.
In summary, the reliability of HFPTA has not been extensively and systematically investigated in a pediatric population. The outcomes of such a study would have useful clinical implications for serial testing in monitoring the hearing of children at risk for deteriorating hearing acuity. The present study aimed to investigate the test-retest reliability of HFPTA thresholds in a large sample of normal-hearing young children tested under headphones in a common clinical setting. The test-retest threshold differences were to be evaluated against the ASHA (1994) criteria to determine the possibility of misdiagnosis of ototoxicity in a normal-hearing pediatric population.
PARTICIPANTS AND METHODS

Participants
A total of 137 children were recruited from a Brisbane area primary (elementary) school, and prior written consent was obtained from the parents or caregivers. Of the 137 children assessed, 125 who had successfully completed both test and retest procedures and who met the inclusion criteria for at least one ear to be included in the analysis were included in the present study. Of these 125 participants, 3 had abnormal hearing in the left ear and 6 had abnormal hearing in the right ear. The participants were aged between 4 and 13 yr, with a mean of 8.38 yr (SD ϭ 2.17). The children were divided into three age groups: 4 to 6 yr (16 males; 16 females); 7 to 9 yr (22 males; 30 females); and 10 to 13 yr (24 males; 17 females). The three age groups were selected to investigate possible age effects on the HFPTA test-retest reliability. Prior ethical clearance for the project was obtained from the Medical Research Ethics Committee of the University of Queensland and the Ethics Committee of Queensland Education, Australia.
For inclusion in the study, participants were required to have hearing thresholds Յ20 dB HL from 0.5 to 4 kHz in at least one ear (Beahan et al. 2009 ). The participants were also required to have normal otoscopic examination results and normal middle ear function as judged by tympanometry results (static compliance Ͼ 0.2 ml and middle ear pressure between ϩ100 and Ϫ200 daPa). This pressure range was extended from the standard of ϽϪ100 daPa of the Jerger (1970) classification system to accommodate peak pressure fluctuations common in the ears of children who do not develop middle ear disease (ASHA 1988; Kei et al. 2005) .
Procedure
Testing was conducted in a sound-treated booth by an experienced audiologist or postgraduate audiology students under supervision. Ambient noise levels were Ͻ30 dBA, as measured by a Brüel & Kjaer (type 2235) sound level meter. Participants were assessed using otoscopy, conventional puretone audiometry, tympanometry, and HFPTA. Otoscopy involved examining the participant's ears for any abnormalities, occlusion, or collapsing ear canals. Tympanometry was performed using a MADSEN Zodiac 901 Middle Ear Analyzer. A probe tone of 226 Hz was delivered to the ear at 85 dB SPL while the pressure was varied from ϩ200 to Ϫ400 daPa at a pump speed of 200 daPa/sec.
A standard audiometer (either GSI 61 or Interacoustics AC40, meeting the Australian Standard [AS IEC 60645.1, 2002] ) and supra-aural TDH39 headphones were used for audiometry in the conventional frequency range (0.25, 0.5, 1, 2, and 4 kHz). The HFPTA thresholds at 8, 9, 10, 11.2, 12.5, 14 , and 16 kHz were measured using an Interacoustics AC40 Clinical Audiometer with Koss R/80 high-frequency headphones. The Koss system has high test-retest reliability of pure-tone thresholds, especially above 11 kHz (Stelmachowicz et al. 1989 ). Calibration of the Interacoustics AC40 Clinical Audiometer was performed by a technician experienced in calibrating audiometers up to 16 kHz. In the calibration process, the right earphone of the audiometer was placed on an ear simulator (6-cc coupler) (Brüel & Kjaer Type 4152 with GRAS 40EN microphone), coupled to a sound level meter (Brüel & Kjaer Type 2235) with a Type 1625 one-third octave band filter. The accuracy of the measurements of the sound level meter was checked regularly using a sound level calibrator (Brüel & Kjaer Type 4230). In calibrating the output of the earphone of the audiometer, strict adherence to the measurement limits, in accordance with Australian Standard (AS IEC 60645. 1, 2002) , was observed in terms of frequency accuracy, sound pressure levels (Ϯ5 dB), harmonic distortion, on/off ratio, and rise/fall times. The reference sound pressure levels used for calibration were those specified in Australian Standard (AS ISO 389.1-2007) for 0.125 to 8 kHz and Australian Standard (AS ISO 389.5-2003) for 8 to 16 kHz. The calibration procedure was repeated for the left earphone to ensure that the above Australian Standards were achieved.
Training was provided for each child who was to receive pure-tone audiometry. During the training session, each child was conditioned to respond to pure tones between 0.5 and 4 kHz at 30 to 50 dB HL presented to either ear. The child was requested to immediately press a button when she/he heard a tone. For young children aged 6 yr or younger who could not respond by reliably pressing a button, play audiometry was employed in which the child was trained to put a peg on a board in response to sound. The presentation tone was reduced in intensity down to the lowest level the child could hear to get the experience of responding to low-intensity sounds.
Once the tester was satisfied that the child had understood all instructions, the testing was commenced. Conventional pure-tone testing began by presenting a 1 kHz tone at 30 dB HL in an ear selected at random. The hearing threshold for that frequency was determined using a modified Hughson-Westlake procedure (Carhart & Jerger 1959 ) with a 5 dB step size. The process was repeated for 2 kHz, 4 kHz, and then 0.5 kHz. The tester then repeated the test for the other ear to obtain thresholds from 0.5 to 4 kHz. At the end of the test, the TDH39 headphones were removed and the child was allowed a short break of 5 to 10 min.
After the break, the tester placed a pair of Koss R/80 high-frequency headphones with standard-sized headband on the child. Extra care was taken with positioning the headphones to ensure that the diaphragm was placed against the concha. Brief instructions were given to the child before testing commenced. A random ear and frequency were selected to begin the testing; subsequent test frequencies were selected randomly. Testing at 8 kHz was included as it was the lowest frequency measured using the Koss R/80 headphones. The same testing procedure was applied to the other ear to obtain hearing thresholds from 8 to 16 kHz. Occasionally, a few children did not respond to signals at the extended high frequencies.
Hence, the number of ears tested varied across the test frequencies and age groups.
After the collection of the first set of HFPTA results, the headphones were removed and a second set of data was collected, yielding two sets of HFPTA thresholds at 8, 9, 10, 11.2, 12.5, 14, and 16 kHz for each participant. The second HFPTA test was performed with the ear order reversed. The order of testing the ear for the next participant was reversed. As headphone placement has been found to be a potential contributor to test-retest differences (Hunter et al. 1996; Stelmachowicz et al. 1989) , removal and replacement of the headphones was conducted to mimic clinical situations where a second test would be conducted on a different day and headphones would need to be reapplied. The entire test procedures, including HFPTA (test and retest), took approximately 60 min for children aged 7 yr or older. The younger children, however, required 10 more minutes to complete all tests.
All the hearing threshold levels were recorded initially in dB HL. The HFPTA hearing levels were then converted to sound pressure levels as per the manufacturer's specifications to enable comparisons with published data. The correction figures for converting dB HL to dB SPL were ϩ18, 14, 17, 21, 17, 19, and 36 dB at 8, 9, 10, 11.2, 12.5, 14 , and 16 kHz, respectively. Table 1 shows the mean and SDs of HFPTA thresholds of the three age groups for the test and retest conditions. The HFPTA data were analyzed using an analysis of variance (ANOVA) with repeated measures on the independent variables: ear, retest, and frequency of pure-tone thresholds. The ANOVA also investigated the effects of gender and age on HFPTA thresholds.
RESULTS
The ANOVA results are shown in Table 2 . The main effects for frequency and age group were significant (p Ͻ 0.05). Significant interactions were found for Frequency ϫ Age group, Ear ϫ Frequency, and Ear ϫ Frequency ϫ Age group. However, none of the other effects and interactions achieved statistical significance.
To further investigate the frequency effect, multiple pairwise comparison tests with Bonferroni adjustment were performed on data averaged across all age groups to determine the difference in mean pure-tone thresholds among the frequencies. The results showed significantly greater threshold values at 16, 14, 12.5, and 10 kHz than at 8, 9, and 11.2 kHz (p Ͻ 0.05). There were no significant differences in mean thresholds between 12.5 and 14 kHz, 8 and 9 kHz, 8 and 11.2 kHz, and 9 and 11.2 kHz.
In view of the age group effect, multiple pairwise comparison tests with Bonferroni adjustment were applied to the data averaged across all frequencies. The results showed significantly elevated pure-tone thresholds for the 4 to 6 yr group (27.6 dB SPL) than for either the 7 to 9 yr group (23.6 dB SPL; p ϭ 0.015) or the 10 to 13 yr group (22.8 dB SPL; p ϭ 0.004). No significant differences in mean thresholds were observed between the two older age groups.
The significant Frequency ϫ Age group interaction indicated that the HFPTA thresholds at various frequencies were different across the three age groups. The significant Ear ϫ Frequency interaction established that the HFPTA thresholds at various frequencies were different between left and right ears. The significant Ear ϫ Frequency ϫ Age group interaction suggests that the pattern of HFPTA thresholds at various frequencies were different between the ears across the three groups.
Because the HFPTA data were heteroskedastic with greater intrasubject variance at some higher frequencies than others, it was not appropriate to apply intraclass correlation coefficients to the data. The heteroskedastic nature of the threshold data may have also affected the initial ANOVA results. To ensure no differences in the mean thresholds between the test and retest conditions, it would be necessary to check the validity of the ANOVA results using a nonparametric statistical measure. Hence, a Wilcoxon Matched-Pairs signed ranks test was applied to the test and retest HFPTA threshold data for each age group, frequency, and ear. In view of the multiple pair comparisons, Bonferroni adjustments were applied, with the results indicating no significant difference between the test and retest thresholds for each age group, frequency, and ear.
To measure the variability of HFPTA thresholds at each test frequency, the differences in HFPTA thresholds across test and retest conditions were expressed in absolute (always positive) values. These absolute differences reflect the changes in measurements regardless of the direction of change. The mean threshold differences (absolute values) at the test frequencies for the left and right ear are displayed in Figures 1 and 2 , respectively. The threshold difference results indicated large variability across the seven frequencies, three age groups, and between the ears. The mean threshold difference ranged from 2.9 to 6.9 dB for the left ear and 2.2 to 7.1 dB for the right ear across all extended high frequencies.
To investigate the variability of HFPTA thresholds across the frequencies for each age group, an ANOVA with repeated measures on frequency was applied to the threshold difference data for each ear (Figs. 1 and 2) . A significant frequency effect was found for the left ear of the 7 to 9 yr group only (F[6,42] ϭ 3.19, p ϭ 0.011). Further analysis using multiple pairwise comparison tests with Bonferroni adjustment showed a significant difference in mean threshold difference (absolute .5 (7.0) 24.1 (11.9) 21.6 (8.6) 30.1 (10.0) 27.8 (9.6) 26.9 (11.1) 27.3 (9.9) 37.0 (13.9) 36.5 ( value) in the left ear between 8 and 14 kHz only (p ϭ 0.042). No significant differences were found for the right ear of the three age groups.
To investigate the variability of HFPTA thresholds across the three age groups at each frequency, a one-way ANOVA was applied to the threshold difference data across the three age groups for each ear at each frequency ( Figs. 1 and 2) . The results revealed a significant difference in mean threshold difference for the left ear at 14 kHz only (F[2] ϭ 6.29, p ϭ 0.003). Analysis using multiple pairwise comparison tests with Bonferroni adjustment showed a significant difference in mean threshold difference between the 7 to 9 yr and 10 to 13 yr group (p ϭ 0.002). The one-way ANOVA results for the right ear showed a significant difference in mean threshold difference at 8 kHz (F[2] ϭ 4.78, p ϭ 0.01) and 12.5 kHz (F[2] ϭ 3.35, p ϭ 0.039). Further analysis using multiple pairwise comparison tests with Bonferroni adjustment revealed a significant difference in mean threshold difference at 8 kHz between the 4 to 6 yr and 10 to 13 yr group (p ϭ 0.009) and at 12.5 kHz between the 7 to 9 yr and 10 to 13 yr group (p ϭ 0.035).
Given the variability in HFPTA thresholds across the test-retest conditions, it is possible that a deterioration of hearing thresholds in serial hearing tests can be interpreted as an indicator of ototoxic cochlea damage for patients receiving anticancer chemotherapy. To investigate this possibility, the exact difference in hearing thresholds between test and retest conditions was calculated. Figure 3 shows the percentage of ears for each age group plotted against the difference in HFPTA threshold (Test 1 Ϫ Test 2) values. The percentages for each age group were normally distributed with the modal value occurring at a threshold difference of 0 dB (i.e., no difference between the test and retest thresholds). A difference threshold of Ϯ10 dB is considered to be within normal variations, given the 5 dB step size used in the modified Hughson-Westlake procedure. Normal variability of HFPTA thresholds was found in 89.9%, 93.0%, and 97.0% of ears of the 4 to 6 yr, 7 to 9 yr, and 10 to 13 yr groups, respectively. The maximum difference in HFPTA thresholds between tests in the current pediatric sample was Ϯ30 dB, Ϯ35 dB, and Ϯ25 dB for the 4 to 6 yr, 7 to 9 yr, and 10 to 13 yr group. Further analysis of the data revealed that the cumulative percentages of ears showing a deterioration of 15 dB or more across all frequencies and test and retest conditions (Test 1 Ϫ Test 2) for the 4 to 6 yr, 7 to 9 yr, and 10 to 13 yr groups were 5.4%, 3.6%, and 2.3%, respectively (Fig. 3) . Figure 4 shows the percentage of HFPTA threshold differences across test-retest conditions that were within Ϯ10 dB at each frequency for each age group. The 10 to 13 yr group obtained the highest percentage (Ն96%) of threshold differences that were within Ϯ10 dB at each frequency among the three groups. The youngest group had the smallest percentage (between 86% and 94%) of normal variability across all frequencies. For the 7 to 9 yr group, greater variability was observed in the 14 to 16 kHz range compared to the 8 to 12.5 kHz range. A Pearson 2 test was applied to the percentages at each frequency across the age groups and showed a significant difference in Fig. 2 . Mean test-retest HFPTA differences (expressed in absolute values) for the right ears of three age groups. N ϭ 29 -30, 51-52, and 37-38 ears for the 4 -6 yr, 7-9 yr, and 10 -13 yr group, respectively. The error bars represent 1 SD from the mean. Fig. 3 . Percentage of ears plotted against threshold difference (Test 1 Ϫ Test 2) for the three age groups. A threshold difference of 15 dB or greater represents a significant deterioration of thresholds across the test-retest conditions. Fig. 4 . Percentage of ears with HFPTA threshold differences across test-retest conditions that were within Ϯ10 dB at each frequency for three age groups.
percentages of ears with normal variability (Ϯ10 dB) at 14 kHz across the age groups ( 2 ϭ 6.28, df ϭ 2, p ϭ 0.043).
The difference threshold data were also examined with reference to two ASHA (1994) criteria for ototoxic damage. Criterion 1 (a 20 dB decrease or worse in threshold at any one frequency) and Criterion 2 (a 10 dB decrease or worse in threshold at any two adjacent frequencies) indicate the possibility of ototoxic damage. In practice, cochlear damage is assumed to have occurred if either criterion is met (Criterion 3). The percentage of ears meeting each of the above criteria for each age group is presented in Figure 5 . Overall, the 4 to 6 yr age group had a high percentage of ears meeting Criterion 1 (13.1%), Criterion 2 (16.4%), and Criterion 3 (24.6%). In contrast, the 10 to 13 yr groups had the smallest proportion of ears meeting the ototoxic criteria.
DISCUSSION
The present study investigated the test-retest reliability of HFPTA in children when headphones were removed and replaced between tests. Overall, the test-retest reliability of HFPTA was high across all age groups with no significant differences in mean hearing thresholds across test and retest conditions at a global level, as indicated by ANOVA with repeated measures. Not surprisingly, the ANOVA results also revealed significant main effects for frequency and age group, as well as Frequency ϫ Age group, Ear ϫ Frequency, and Ear ϫ Frequency ϫ Age group interactions. These results basically reflect the characteristics of the HFPTA data obtained from children, as discussed in Beahan et al. (2009) . Essentially, the HFPTA thresholds at various frequencies were different between ears across the three age groups. The HFPTA data also showed that the mean threshold averaged over the three age groups increased with frequency, except at 11.2 kHz ( Table 1) . The 4 to 6 yr group had raised HFPTA thresholds when compared with the older age groups.
The test-retest reliability of HFPTA was investigated further by examining the difference in thresholds between the test and retest results for each frequency, ear, and age group using a Wilcoxon Matched-Pairs signed ranks test. The results confirmed the ANOVA results that there was no significant difference in thresholds between the test and retest conditions.
An alternative way to measure the variability of HFPTA thresholds was to express the differences in thresholds across test and retest conditions in absolute values. A close examination of the mean absolute threshold differences indicated differences of 2.2 to 7.1 dB across all frequencies for both ears of the three age groups (Figs. 1 and 2) . The mean absolute threshold differences varied, depending on the frequency, ear, and age group. These results are comparable to but smaller than the 4 to 8 dB range reported by Hunter et al. (1996) .
The characteristics of the variability of the absolute threshold difference indicated a significantly high mean threshold difference at 14 kHz for the left ear of the 7 to 9 yr group (Fig.  1 ). This mean threshold difference is also significantly greater than that of the 10 to 13 yr group at the same frequency. For the right ear, there was no significant frequency effect for any age group. However, the mean absolute threshold difference at 8 kHz was significantly higher for the 4 to 6 yr group than for the 10 to 13 yr group (Fig. 2) . At 12.5 kHz, the 7 to 9 yr group acquired a significantly higher mean absolute threshold difference than that of the 10 to 13 yr group. In summary, these findings reveal the heterogeneity of the three age groups with respect to the variability of HFPTA thresholds across the test-retest conditions. The three age groups performed differently in the HFPTA under the test and retest conditions. There were large discrepancies in thresholds, leading to an apparent improvement or deterioration of hearing thresholds. The maximum difference in HFPTA thresholds between tests in the current pediatric sample was in excess of Ϯ25 dB for each age group. Although the occurrence of large discrepancies was rare, this incident could have triggered an alarm for a substantial shift in threshold. Auspiciously, the majority of threshold differences fell within the clinically acceptable range of Ϯ10 dB (Fig. 3) . The proportions of ears demonstrating normal variability (within Ϯ10 dB) for the 4 to 6 yr, 7 to 9 yr, and 10 to 13 yr age groups were 89.9%, 93.0%, and 97.0%, respectively. These results are comparable to Ն94% across all test frequencies from 10 to 18 kHz reported by Frank (1990) , Frank and Dreisbach (1991) , and Schmuziger et al. (2004) for normalhearing adults.
When the differences in test-retest thresholds were examined across the frequencies for the three age groups (Fig. 4) , the oldest group had the highest percentage of ears (Ͼ96%), demonstrating normal variability (within Ϯ10 dB) for all frequencies. The two younger groups showed moderate reliability across the frequencies, with the least reliability occurring at 14 and 16 kHz. These results suggest that children aged 4 to 9 yr with a difference in thresholds exceeding 10 dB at these frequencies may not necessarily have a genuine threshold shift. Clinicians should be aware of the higher false-positive rate of diagnosing hearing impairment in young children at these extended high frequencies than at frequencies Ͻ14 kHz. This finding may have important clinical implications in monitoring for ototoxicity in young children. As hearing damage caused by anticancer drugs starts from the extended high-frequency region and progresses to the lower frequencies with increasing dosage, HFPTA has the potential to detect ototoxic damage at the earliest possible stage.
In the present study conducted on normal-hearing children, the test-retest threshold data revealed that the percentages of ears showing a deterioration of 15 dB or more across all frequencies for the 4 to 6 yr, 7 to 9 yr, and 10 to 13 yr age groups were 5.4%, 3.6%, and 2.3%, respectively (Fig. 3 ). When these difference threshold data were checked against the ASHA (1994) criteria for ototoxic damage, the 10 to 13 yr group had the lowest false-positive rates with 2.5%, 6.3%, and 7.6% meeting the Criteria 1, 2, and 3, respectively (Fig. 5) . These rates are higher than the corresponding rates of 0%, 2% and 2%, respectively, reported by Frank (2001) for young adults (aged 18 -25 yr). The corresponding false-positive rates for the 7 to 9 yr group were higher than those obtained from the 10 to 13 yr group with 5%, 9%, and 11% meeting the Criteria 1, 2, and 3, respectively. Although not ideal, these rates are not excessively high as to abandon the use of the HFPTA for monitoring ototoxicity in children aged 7 yr or older. However, clinicians should be cautious in interpreting test findings in serial testing for monitoring ototoxicity. In case of doubt, the clinician should get additional clinical information from other objective tests such as auditory steady state response and distortion product otoacoustic emissions. Unfortunately, without appropriate modifications, these objective tests may not be able to test reliably up to 16 kHz for young children.
Despite the above promising results from older children, the 4 to 6 yr group obtained the highest false-positive rates with 13.1%, 16.4%, and 24.6% meeting the Criterion 1, 2, and 3, respectively. This means that about one-quarter of normalhearing children in this group could have been misdiagnosed as having cochlear hearing impairment caused by ototoxicity. These false-positive rates are high when compared with those obtained from adults (Frank 2001; Schmuziger et al. 2004 ). We, therefore, recommend that HFPTA may not be a suitable test to monitor for ototoxicity for this age group.
In summary, given the high test-retest reliability of HFPTA in children aged 7 yr or older with a moderately low falsepositive rate, the HFPTA holds promise as a valuable tool in detecting a significant deterioration in hearing thresholds caused by ototoxicity or other causes. However, given the nonzero false-positive rate, the interpretation of HFPTA findings should be made with caution with due attention given to the age of subjects and test frequency. An additional factor which could affect test-retest reliability of HFPTA is the time between tests. The test-retest reliability of pure-tone thresholds has been found to decrease as the intertest interval is increased (Schmuziger et al. 2004) . This factor has to be taken into account when interpreting HFPTA findings between tests.
Several factors could have contributed to the greater testretest variability of HFPTA thresholds of the youngest group in comparison to the older groups. First, the 4-to 6-yr-old children may have shorter attention span and persistence than their older counterparts in performing the listening task. During the test, these young children required considerable encouragement to enable them to focus on the listening task. Second, these young children may have poorer listening skills in detecting the threshold of hearing than their older peers. Last, younger children were more restless than older children in terms of head and limb movements, leading to variant earphone placements. Variable earphone placements may result in different hearing thresholds, especially in the high frequencies where standing waves in the ear canal produce variable maximum and minimum sound pressure changes inside the ear canal (Hickling 1966; Beiter & Talley 1976) . In the event of an apparent significant deterioration in hearing sensitivity in young children, the test should be repeated when the child's attention has been restored.
While the present study estimated the false-positive rates of HFPTA in detecting significant shifts in threshold in normalhearing children, further research is necessary to establish the sensitivity and specificity of the HFPTA in assessing hearing acuity in pediatric oncology patients. However, obtaining HFPTA threshold data from these patients can be a challenging task in view of their health status.
In conclusion, the HFPTA can be administered to children aged 7 yr or older with high reliability. There was no significant difference in mean HFPTA threshold across test and retest conditions. Overall, the 10-to 13-yr-old children displayed higher test-retest reliability than the 7-to 9-yr-old and 4-to 6-yr-old children, with the oldest group demonstrating normal variability (within Ϯ10 dB) in 97% of ears tested. In identifying significant deterioration of hearing thresholds across test-retest conditions in accordance with the ASHA (1994) ototoxicity criteria, the 7 to 9 yr and 10 to 13 yr groups demonstrated false-positive rates of 11% and 7.6%, respectively. The HFPTA test holds promise as a useful tool to identify hearing loss in the extended high-frequency range (Ͼ8 kHz) for children aged 7 yr or older. In interpreting HFPTA results, a clinician should take into consideration the age and frequency effects, nonzero false-positive rates, and special medical conditions, such as illness and effects of medication on child's attention, which may affect the reliability of threshold results. However, in view of the high false-positive rates for the 4 to 6 yr group, HFPTA is not recommended in serial testing for monitoring hearing sensitivity unless an effective objective test of auditory function is used alongside the HFPTA to check for consistency of test results.
